Efficacy of Systemic Bevacizumab for Recurrent Respiratory Papillomatosis with Pulmonary Involvement-Reference-Cited by-同舟云学术

Efficacy of Systemic Bevacizumab for Recurrent Respiratory Papillomatosis with Pulmonary Involvement

Published:2023-07-20 Issue: Volume: Page:
ISSN:0023-852X
Container-title:The Laryngoscope
language:en
Short-container-title:The Laryngoscope

Author:

So Raymond J.¹^ORCID,Hidalgo Lopez Julio C.²,Ballestas Samir A.²,Klein Adam M.²,Steuer Conor³,Shin Dong M.³,Abousaud Marin⁴,Teng Yong³,Saba Nabil F.³,Tkaczuk Andrew T.²,Schaefer Eric S.⁵,Seiwert Tanguy Y.⁶,McClellan Kim⁷,Best Simon R.¹

Affiliation:

1. Department of Otolaryngology—Head and Neck Surgery Johns Hopkins University School of Medicine Baltimore Maryland U.S.A.

2. Department of Otolaryngology—Head and Neck Surgery Emory University Atlanta Georgia U.S.A.

3. Department of Hematology and Medical Oncology Emory University Atlanta Georgia U.S.A.

4. Department of Pharmaceutical Sciences Emory University Atlanta Georgia U.S.A.

5. Highlands Oncology Fayetteville Arkansas U.S.A.

6. Department of Oncology Johns Hopkins University School of Medicine Baltimore Maryland U.S.A.

7. Recurrent Respiratory Papillomatosis Foundation Lawrenceville New Jersey U.S.A.

Publisher

Wiley

Subject

Otorhinolaryngology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/lary.30893

Reference25 articles.

1. Recurrent Respiratory Papillomatosis: A Review

2. Recurrent Respiratory Papillomatosis

3. Sites of Predilection in Recurrent Respiratory Papillomatosis

4. Ad hoc committee on service delivery in the schools. American speech‐language‐hearing association;Definitions of communication disorders and variations;ASHA Suppl,1993

5. Systemic bevacizumab for recurrent respiratory papillomatosis: A national survey

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Quantifying Bevacizumab Efficacy in Recurrent Respiratory Papillomatosis;The Laryngoscope;2024-08-29

2. A Consensus Statement on the Administration of Systemic Bevacizumab in Patients with Recurrent Respiratory Papillomatosis;The Laryngoscope;2024-08-03

3. Juvenile onset recurrent respiratory papillomatosis: What do we know in 2024 ?;Tumour Virus Research;2024-06

4. Systemic Bevacizumab for Recurrent Respiratory Papillomatosis: A Single Institution's Experience;The Laryngoscope;2024-03-25

5. Factors Associated with Iatrogenic Laryngeal Injury in Recurrent Respiratory Papillomatosis;Otolaryngology–Head and Neck Surgery;2023-12-20